Decision makers are generally used to evaluating data according to its internal validity, as has been the case for RCTs, however by doing this, understanding for the specifics for a disease or inte
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding breast cancer. We also aim to understand how these differ in the ability to conduct outcomes research using the available data.
